Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alkermes (ALKS) EBT: 2010-2025

Historic EBT for Alkermes (ALKS) over the last 15 years, with Sep 2025 value amounting to $100.7 million.

  • Alkermes' EBT fell 8.60% to $100.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $401.0 million, marking a year-over-year increase of 20.71%. This contributed to the annual value of $443.8 million for FY2024, which is 5.27% up from last year.
  • Alkermes' EBT amounted to $100.7 million in Q3 2025, which was down 3.91% from $104.8 million recorded in Q2 2025.
  • Over the past 5 years, Alkermes' EBT peaked at $281.8 million during Q2 2023, and registered a low of -$67.4 million during Q3 2022.
  • For the 3-year period, Alkermes' EBT averaged around $99.7 million, with its median value being $100.7 million (2025).
  • Per our database at Business Quant, Alkermes' EBT slumped by 1,310.54% in 2021 and then spiked by 947.61% in 2023.
  • Alkermes' EBT (Quarterly) stood at $127.3 million in 2021, then declined by 10.04% to $114.5 million in 2022, then plummeted by 49.06% to $58.3 million in 2023, then spiked by 191.32% to $169.9 million in 2024, then declined by 8.60% to $100.7 million in 2025.
  • Its EBT stands at $100.7 million for Q3 2025, versus $104.8 million for Q2 2025 and $25.5 million for Q1 2025.